Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reyataz in HIV-Associated Lipodystrophy Syndrome (REAL Study)
NCT00135356Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2005
- Primary completion
- Jul 2007
- Countries
- 9
01
Overview
A Phase 4 trial of atazanavir in HIV-associated lipodystrophy syndrome (HALS), sponsored by Bristol Myers Squibb. Started Jul 2005; status: completed.
02
Drugs
atazanavir
03
Conditions
HIV-associated lipodystrophy syndrome (HALS)
Beyond the preview
Go deeper on NCT00135356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135356.